Abstract
During the last 25 years, antibody-mediated rejection of the cardiac allograft has evolved from a relatively obscure concept to a recognized clinical complication in the management of heart transplant patients. Herein we report the consensus findings from a series of meetings held between 2010-2012 to develop a Working Formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection. The diagnostic criteria for its morphologic and immunopathologic components are enumerated, illustrated, and described in detail. Numerous challenges and unresolved clinical, immunologic, and pathologic questions remain to which a Working Formulation may facilitate answers.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of Heart and Lung Transplantation |
| Vol/bind | 32 |
| Udgave nummer | 12 |
| Sider (fra-til) | 1147-62 |
| Antal sider | 16 |
| ISSN | 1053-2498 |
| DOI | |
| Status | Udgivet - dec. 2013 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS